Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 521–540 of 17,529 recalls

July 9, 2025· Imprimis NJOF, LLC

Recalled Item: Epinephrine Lidocaine HCL

The Issue: Sub-Potent Drug: Subpotent assay results during stability testing

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 9, 2025· Ascend Laboratories, LLC

Recalled Item: Rizatriptan Benzoate Tablets

The Issue: CGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 9, 2025· Ascend Laboratories, LLC

Recalled Item: Rizatriptan Benzoate Tablets

The Issue: CGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 7, 2025· MEDLINE INDUSTRIES, LP - Northfield

Recalled Item: Good Neighbor Pharmacy

The Issue: Subpotent Drug- isopropyl alcohol levels fall below the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 7, 2025· MEDLINE INDUSTRIES, LP - Northfield

Recalled Item: CURAD Alcohol Prep Pads

The Issue: Subpotent Drug- isopropyl alcohol levels fall below the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 7, 2025· MEDLINE INDUSTRIES, LP - Northfield

Recalled Item: ReliOn

The Issue: Subpotent Drug- isopropyl alcohol levels fall below the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 7, 2025· MEDLINE INDUSTRIES, LP - Northfield

Recalled Item: Medline Alcohol Prep Pads

The Issue: Subpotent Drug- isopropyl alcohol levels fall below the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 7, 2025· MEDLINE INDUSTRIES, LP - Northfield

Recalled Item: RITE AID PHARMACY

The Issue: Subpotent Drug- isopropyl alcohol levels fall below the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 7, 2025· MEDLINE INDUSTRIES, LP - Northfield

Recalled Item: H-E-B

The Issue: Subpotent Drug- isopropyl alcohol levels fall below the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 5, 2025· FDC Limited

Recalled Item: Timolol Maleate Ophthalmic Solution USP

The Issue: Defective Container: spike of the cap becomes lodged

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 2, 2025· Lupin Pharmaceuticals Inc.

Recalled Item: Amlodipine and Benazepril HCl Capsules USP 2.5 mg/10 mg

The Issue: Labeling: Incorrect or Missing Lot and/or Exp Date:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 1, 2025· Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles

Recalled Item: PERIPHERAL PARENTERAL NUTRITION

The Issue: Lack of Processing Controls; prescriptions were compounded in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
June 30, 2025· Cipla USA, Inc.

Recalled Item: Budesonide Inhalation Suspension

The Issue: Lack of Assurance of Sterility: A market complaint

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
June 30, 2025· Dr. Reddy's Laboratories, Inc.

Recalled Item: Omeprazole Delayed-release Capsules

The Issue: Presence of foreign tablets/capsules: presence of foreign Divalproex

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
June 30, 2025· Breckenridge Pharmaceutical, Inc.

Recalled Item: Duloxetine Delayed-Release Capsules

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
June 27, 2025· Lupin Pharmaceuticals Inc.

Recalled Item: clomiPRAMINE Hydrochloride Capsules USP 25 mg

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 27, 2025· Sandoz Inc

Recalled Item: Cefazolin for Injection

The Issue: Labeling: Label Mix-Up; cartons of Cefazolin for Injection,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
June 27, 2025· Sandoz Inc

Recalled Item: Buffered Penicillin G Potassium for Injection

The Issue: Labeling: Label Mix-Up; Some vials of Cefazolin for

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
June 26, 2025· AvKARE

Recalled Item: Pitavastatin Tablets

The Issue: Failed Impurity/Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
June 26, 2025· AvKARE

Recalled Item: Pitavastatin Tablets

The Issue: Failed Impurity/Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund